Executive panel: Navigating the new healthtech funding landscape


  • After two record breaking years of digital health investment, deal-flow and commercial milestones, has innovation been hit by the COVID-19 pandemic? 
  • What effects has COVID-19 had on health-tech investment strategy and where are the opportunities for innovative solutions to emerge? 
  • Is the current crisis prompting a fundamental shift in favour of healthcare digitisation?

Anat Naschitz, Managing Director, Orbimed
Jessica Federer, Partner, Boston Millennia Partners
Steve Tolle, Partner, HLM Ventures
David Kim, Managing Partner, DigiTx Partners

Moderator: Adam Dakin, Managing Partner, Dreamit Ventures
Written By